Hyloris Replaces Leadership After Continued Transaction Woes
The Company’s CEO, CFO and CLO Will All Step Down
Marking a further development in the story of Hyloris’ in-licensing deal with QliniQ, the company’s board has announced significant leadership and organizational changes to address potential concerns.
